ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 153 filers reported holding ACLARIS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,850,000 | -33.9% | 1,000,000 | 0.0% | 0.02% | -30.4% |
| Q2 2023 | $10,370,000 | +8.6% | 1,000,000 | -15.3% | 0.02% | +9.5% |
| Q1 2023 | $9,546,200 | -13.4% | 1,180,000 | +68.6% | 0.02% | -19.2% |
| Q4 2022 | $11,025,000 | +0.1% | 700,000 | 0.0% | 0.03% | -3.7% |
| Q3 2022 | $11,018,000 | +26.3% | 700,000 | +12.0% | 0.03% | +35.0% |
| Q2 2022 | $8,725,000 | +19.1% | 625,000 | +47.1% | 0.02% | +42.9% |
| Q1 2022 | $7,327,000 | -44.0% | 425,000 | -52.8% | 0.01% | -41.7% |
| Q4 2021 | $13,086,000 | -32.4% | 899,997 | -16.3% | 0.02% | -36.8% |
| Q3 2021 | $19,357,000 | -44.9% | 1,075,366 | -46.2% | 0.04% | -44.9% |
| Q2 2021 | $35,120,000 | -56.4% | 2,000,000 | -37.5% | 0.07% | -58.2% |
| Q1 2021 | $80,640,000 | +453.9% | 3,200,000 | +42.2% | 0.16% | +415.6% |
| Q4 2020 | $14,558,000 | +126.6% | 2,250,000 | -10.0% | 0.03% | +100.0% |
| Q3 2020 | $6,425,000 | +58.6% | 2,500,000 | 0.0% | 0.02% | +60.0% |
| Q2 2020 | $4,050,000 | +94.7% | 2,500,000 | +25.0% | 0.01% | +66.7% |
| Q1 2020 | $2,080,000 | +57.2% | 2,000,000 | +185.7% | 0.01% | +100.0% |
| Q4 2019 | $1,323,000 | +75.0% | 700,000 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $756,000 | -50.7% | 700,000 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $1,533,000 | -88.6% | 700,000 | +55.6% | 0.00% | -88.2% |
| Q1 2017 | $13,419,000 | +9.9% | 450,000 | 0.0% | 0.03% | +3.0% |
| Q4 2016 | $12,213,000 | – | 450,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |